| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.34B | 1.95B | 1.81B | 1.91B | 1.74B | 1.32B |
| Gross Profit | 672.40M | 632.50M | 599.60M | 568.80M | 523.00M | 422.90M |
| EBITDA | 207.40M | 158.70M | 147.80M | 124.10M | 110.60M | 101.30M |
| Net Income | 7.00M | 57.60M | 46.30M | 35.90M | 32.30M | 25.40M |
Balance Sheet | ||||||
| Total Assets | 3.82B | 1.27B | 1.20B | 1.30B | 1.34B | 1.29B |
| Cash, Cash Equivalents and Short-Term Investments | 197.70M | 81.80M | 57.30M | 116.50M | 99.60M | 119.10M |
| Total Debt | 1.15B | 207.70M | 250.30M | 315.50M | 327.60M | 361.80M |
| Total Liabilities | 2.39B | 780.70M | 754.50M | 837.90M | 873.10M | 868.30M |
| Stockholders Equity | 1.43B | 492.00M | 450.20M | 459.80M | 465.60M | 423.20M |
Cash Flow | ||||||
| Free Cash Flow | 15.00M | 122.20M | 79.60M | 61.60M | 42.90M | 62.50M |
| Operating Cash Flow | 59.80M | 165.60M | 112.00M | 99.00M | 92.90M | 102.70M |
| Investing Cash Flow | -512.60M | -43.40M | -31.70M | -31.30M | -50.00M | -17.60M |
| Financing Cash Flow | 488.00M | -85.50M | -98.70M | -81.50M | -69.40M | -58.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.74B | 7.89 | 15.61% | 1.62% | 2.31% | 8.35% | |
75 Outperform | £2.94B | 18.83 | 14.99% | 2.06% | 9.52% | 17.22% | |
69 Neutral | £1.61B | 164.76 | 0.73% | 0.79% | 25.76% | -73.03% | |
68 Neutral | £12.75B | 13.62 | 8.44% | 2.98% | -2.16% | -24.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | £462.06M | 9.66 | 14.17% | 7.01% | 5.67% | 22.05% |